Sirona Biochem Corp.
SRBCF · OTC
10/31/2023 | 10/31/2022 | 10/31/2021 | 10/31/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.23 | -0.18 | 0.43 | 0.71 |
| FCF Yield | -9.39% | -7.37% | -4.82% | -3.85% |
| EV / EBITDA | -8.71 | -8.42 | -19.49 | -13.56 |
| Quality | ||||
| ROIC | 1,259.21% | -446.87% | -264.83% | -285.82% |
| Gross Margin | -82.71% | 92.53% | 74.34% | 48.79% |
| Cash Conversion Ratio | 0.69 | 0.61 | 0.94 | 0.51 |
| Growth | ||||
| Revenue 3-Year CAGR | -49.37% | 85.24% | 25.45% | -56.44% |
| Free Cash Flow Growth | 19.29% | -0.89% | 0.04% | 39.34% |
| Safety | ||||
| Net Debt / EBITDA | -0.69 | -0.01 | -0.03 | 0.07 |
| Interest Coverage | -11.93 | -132.17 | -704.48 | -307.68 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -1,752.88 | -1,863.07 | -975.97 | -2,470.87 |